Literature DB >> 11106580

Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis.

A S de Hooge1, F A van De Loo, O J Arntz, W B van Den Berg.   

Abstract

Interleukin-6 (IL-6) is highly produced during arthritis but its exact function is still unknown. In this study we examined if IL-6, apart from its role in immunity, was involved in the local inflammatory response in experimental arthritis. IL-6 deficient (IL-6(-/-)) and wild-type mice were first compared in the antigen-induced arthritis model. IL-6 deficiency resulted in a mild, transient inflammation whereas wild-type mice developed a chronic, destructive synovitis. Wild-type mice immunized with one-tenth of the normal antigen dose still developed chronic arthritis despite low antibody levels, excluding reduced humoral immunity in IL-6(-/-) mice as a crucial phenomenon. In addition, passive immune-complex-induced arthritis did not differ between wild-type and IL-6(-/-) mice. Another option is reduced levels of Th1 cells in IL-6(-/-) mice. However, transfer of antigen-specific wild-type lymph node cells to IL-6(-/-) mice enhanced acute joint inflammation and increased cartilage damage but still could not sustain chronic inflammation, suggesting involvement of nonimmune elements of IL-6 activity in chronicity. In line with this, nonimmunologically mediated zymosan-induced arthritis developed similarly in the first week, but only wild-type mice developed chronic synovitis. These results indicate an important role for IL-6 in propagation of joint inflammation, potentially independent of its role in immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106580      PMCID: PMC1885768          DOI: 10.1016/S0002-9440(10)64846-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Studies on antigen-induced arthritis in mice. III. Cell and serum transfer experiments.

Authors:  D Brackertz; G F Mitchell; M A Vadas; I R Mackay
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation.

Authors:  P De Sepulveda; S Ilangumaran; R Rottapel
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

4.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

Review 5.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement.

Authors:  E C Keystone; H U Schorlemmer; C Pope; A C Allison
Journal:  Arthritis Rheum       Date:  1977 Sep-Oct

7.  Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal.

Authors:  J L Ceuppens; M L Baroja; K Lorre; J Van Damme; A Billiau
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

8.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

9.  Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice.

Authors:  D Brackertz; G F Mitchell; I R Mackay
Journal:  Arthritis Rheum       Date:  1977-04

Review 10.  SOCS: physiological suppressors of cytokine signaling.

Authors:  D L Krebs; D J Hilton
Journal:  J Cell Sci       Date:  2000-08       Impact factor: 5.285

View more
  20 in total

1.  Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Authors:  Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

2.  A longitudinal analysis of serum cytokines in the Hartley guinea pig model of osteoarthritis.

Authors:  J L Huebner; D R Seifer; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2007-01-05       Impact factor: 6.576

3.  Inflammatory response in patients with active and inactive osteoarthritis.

Authors:  Antoaneta Toncheva; Mimi Remichkova; Krassimira Ikonomova; Petya Dimitrova; Nina Ivanovska
Journal:  Rheumatol Int       Date:  2009-01-30       Impact factor: 2.631

4.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.

Authors:  Jennifer M McCoy; Joan R Wicks; Laurent P Audoly
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

5.  Bone marrow cells carrying the env-pX transgene play a role in the severity but not prolongation of arthritis in human T-cell leukaemia virus type-I transgenic rats: a possible role of articular tissues carrying the transgene in the prolongation of arthritis.

Authors:  Asami Abe; Akihiro Ishizu; Hitoshi Ikeda; Hiroko Hayase; Takahiro Tsuji; Yukiko Miyatake; Muneharu Tsuji; Kazunori Fugo; Toshiaki Sugaya; Masato Higuchi; Takeo Matsuno; Takashi Yoshiki
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

6.  Innate immunity genes influence the severity of acute appendicitis.

Authors:  Fernando A Rivera-Chavez; Dixie L Peters-Hybki; Robert C Barber; Guy M Lindberg; Ishwarlal Jialal; Robert S Munford; Grant E O'Keefe
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

7.  Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes.

Authors:  M Mathy-Hartert; I Jacquemond-Collet; F Priem; C Sanchez; C Lambert; Y Henrotin
Journal:  Inflamm Res       Date:  2009-07-05       Impact factor: 4.575

Review 8.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

9.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 10.  Lessons from animal models of arthritis over the past decade.

Authors:  Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.